Pfizer Increases Profit Outlook Following Strong COVID Sales
Reported 3 months ago
Pfizer has raised its annual profit forecast, now expecting earnings between $2.45 and $2.65 per share, due to better-than-expected sales of its COVID-19 vaccine and antiviral treatment.